Regenerex Pharma (RGPX) Non-Current Debt (2023 - 2024)

Regenerex Pharma (RGPX) reported Non-Current Debt of $184232.0 for Q1 2024, up 6479.71% quarter-over-quarter from $2800.0 in Q4 2023.

Regenerex Pharma (RGPX) Non-Current Debt (2023 - 2024) Analysis & Trends

Regenerex Pharma (RGPX) has 2 years of Non-Current Debt data on file, last reported at $184232.0 in Q1 2024.

Non-Current Debt for Q1 2024 came in at $184232.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $184232.0 (changed N/A YoY), and the FY2024 annual result was $184232.0, changed N/A from the prior year.
Non-Current Debt improved to $184232.0 in Q1 2024 per RGPX's latest filing, from $2800.0 in the prior quarter.
Over five years, Non-Current Debt peaked at $184232.0 in Q1 2024 and troughed at $2800.0 in Q3 2023.

Download Data